Shanghai Kangdelai Medical Devices Co., Ltd. (hereinafter referred to as the “Company”) was founded in 2006 and is located in Jiading District, Shanghai, focusing on R&D, production and sales of interventional medical devices. The company is one of the few medical device manufacturers in China with complete industrial capabilities such as independent mold development, product research and development, equipment development, and independent sterilization. The company has successively passed ISO13485, CE and FDA certifications, and its products are exported to more than 40 countries and regions on the six continents of BE. According to the results of the 2018 industry research report issued by Sullivan Consulting in the US, we ranked second among domestic brands in the field of intrauterine interventional devices in China, and ranked first among domestic brands in the field of PCI enabled devices. The company has seven subsidiaries, each focusing on research and development of medical devices related to intervention and implantation in different treatment fields. The company adheres to the corporate culture of “team is the cornerstone of entrepreneurship, innovation is the source of development, and execution is the key to victory”, continuously enhances its ability to innovate independently, and develops independent intellectual property products. By the end of August 2019, the company had 27 domestic registered products, 28 CE certified products, 10 FDA-certified products, 60 authorized patents, 77 patents pending approval, and 5 software copyrights. The company has successively received many honorary titles such as Shanghai High-tech Enterprises, Shanghai Science and Technology Giants, Shanghai “Special, Special, New” Enterprises, Shanghai Patent Pilot Enterprises, etc., and has received support for projects such as the Shanghai Torch Program, the Shanghai High-tech Achievement Transformation Project, the Shanghai Science and Technology Support Project, the Shanghai Technology Innovation Fund, the Shanghai Science and Technology Talent Program Project, the National Science and Technology Innovation Fund, the National Science and Technology Innovation Entrepreneurship Talent of the Ministry of Science and Technology, and the National “Ten Thousand Thousand Thousand Thousand Thousand Year Plan” Science and Technology Entrepreneurship Leaders. The company currently has more than 700 employees, and its main production base is located in Jiading District, Shanghai. In the future, with the development vision of “becoming a world-renowned implantable medical device group led by scientific and technological innovation”, the company will continue to adhere to the development concept of “science and technology serves health, quality creates extraordinary” to provide support for the development of China's medical device industry and contribute to global human health!
No Data
No Data